ASX - By Stock
|
MRM |
Re:
Ann: 2024 Half Year Results Investor Presentation
|
|
SuperJames
|
34 |
8.9K |
0 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
34
|
8.9K
|
0
|
|
ASX - By Stock
|
DSK |
Re:
Why The Big Drop Today?
|
|
SuperJames
|
46 |
23K |
5 |
06/01/23 |
06/01/23 |
ASX - By Stock
|
46
|
23K
|
5
|
|
ASX - By Stock
|
DSK |
Re:
Why The Big Drop Today?
|
|
SuperJames
|
46 |
23K |
11 |
20/12/22 |
20/12/22 |
ASX - By Stock
|
46
|
23K
|
11
|
|
ASX - By Stock
|
DSK |
Re:
Why The Big Drop Today?
|
|
SuperJames
|
46 |
23K |
0 |
01/12/22 |
01/12/22 |
ASX - By Stock
|
46
|
23K
|
0
|
|
ASX - By Stock
|
RAS |
Re:
RAS General Discussion
|
|
SuperJames
|
68 |
28K |
3 |
01/12/22 |
01/12/22 |
ASX - By Stock
|
68
|
28K
|
3
|
|
ASX - By Stock
|
RAS |
Re:
Ann: NT Lithium Project Tenement Granted
|
|
SuperJames
|
217 |
57K |
3 |
21/09/22 |
21/09/22 |
ASX - By Stock
|
217
|
57K
|
3
|
|
ASX - By Stock
|
RAS Lithium |
Re:
RAS Rerate just the beginning
|
|
SuperJames
|
306 |
143K |
8 |
08/09/22 |
08/09/22 |
ASX - By Stock
|
306
|
143K
|
8
|
|
ASX - By Stock
|
RAS Lithium |
Re:
RAS Rerate just the beginning
|
|
SuperJames
|
306 |
143K |
3 |
08/09/22 |
08/09/22 |
ASX - By Stock
|
306
|
143K
|
3
|
|
ASX - By Stock
|
RAS |
Re:
Ann: NT Lithium Project Review Works Confirm High Grade Lithium
|
|
SuperJames
|
699 |
183K |
1 |
07/09/22 |
07/09/22 |
ASX - By Stock
|
699
|
183K
|
1
|
|
ASX - By Stock
|
DSK |
Re:
Ann: DSK FY22 Investor Presentation
|
|
SuperJames
|
62 |
29K |
0 |
02/09/22 |
02/09/22 |
ASX - By Stock
|
62
|
29K
|
0
|
|
ASX - By Stock
|
RAS Lithium |
Re:
RAS Gold results potentially even stronger
|
|
SuperJames
|
339 |
112K |
1 |
30/08/22 |
30/08/22 |
ASX - By Stock
|
339
|
112K
|
1
|
|
ASX - By Stock
|
RAS Lithium |
Re:
RAS Gold results potentially even stronger
|
|
SuperJames
|
339 |
112K |
2 |
30/08/22 |
30/08/22 |
ASX - By Stock
|
339
|
112K
|
2
|
|
ASX - By Stock
|
RAS Lithium |
Re:
RAS Gold results potentially even stronger
|
|
SuperJames
|
339 |
112K |
3 |
30/08/22 |
30/08/22 |
ASX - By Stock
|
339
|
112K
|
3
|
|
ASX - By Stock
|
RAS |
Re:
Ann: NT Lithium Project Review Works Confirm High Grade Lithium
|
|
SuperJames
|
699 |
183K |
6 |
22/08/22 |
22/08/22 |
ASX - By Stock
|
699
|
183K
|
6
|
|
ASX - By Stock
|
RAS |
Re:
Ann: NT Lithium Project Review Works Confirm High Grade Lithium
|
|
SuperJames
|
699 |
183K |
2 |
15/08/22 |
15/08/22 |
ASX - By Stock
|
699
|
183K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Study 7 Confirms ColoSTAT Meets Primary Endpoint
|
|
SuperJames
|
17 |
6.6K |
11 |
04/04/22 |
04/04/22 |
ASX - By Stock
|
17
|
6.6K
|
11
|
|
ASX - By Stock
|
CHR |
Re:
$1 Party
|
|
SuperJames
|
47 |
18K |
2 |
19/01/22 |
19/01/22 |
ASX - By Stock
|
47
|
18K
|
2
|
|
ASX - By Stock
|
CHR |
Re:
Chart
|
|
SuperJames
|
261 |
75K |
2 |
18/01/22 |
18/01/22 |
ASX - By Stock
|
261
|
75K
|
2
|
|
ASX - By Stock
|
CHR |
Re:
Ann: Charger's targeting suggests Large Lithium System at Bynoe
|
|
SuperJames
|
15 |
7.8K |
5 |
17/01/22 |
17/01/22 |
ASX - By Stock
|
15
|
7.8K
|
5
|
|
ASX - By Stock
|
CHR |
Re:
Chart
|
|
SuperJames
|
261 |
75K |
5 |
13/01/22 |
13/01/22 |
ASX - By Stock
|
261
|
75K
|
5
|
|
ASX - By Stock
|
CHR |
Re:
Ann: Becoming a substantial holder
|
|
SuperJames
|
9 |
3.1K |
1 |
12/01/22 |
12/01/22 |
ASX - By Stock
|
9
|
3.1K
|
1
|
|
ASX - By Stock
|
CHR |
Re:
Ann: Becoming a substantial holder
|
|
SuperJames
|
9 |
3.1K |
6 |
11/01/22 |
11/01/22 |
ASX - By Stock
|
9
|
3.1K
|
6
|
|
Charts
|
RHY |
Re:
RHY charts
|
|
SuperJames
|
80 |
44K |
6 |
05/11/21 |
05/11/21 |
Charts
|
80
|
44K
|
6
|
|
ASX - By Stock
|
CHR |
Re:
Ann: Charger confirms emerging Lithium targets at Bynoe
|
|
SuperJames
|
39 |
15K |
8 |
04/11/21 |
04/11/21 |
ASX - By Stock
|
39
|
15K
|
8
|
|
ASX - By Stock
|
DSK |
Re:
DSK should be $5 by now
|
|
SuperJames
|
46 |
27K |
4 |
03/11/21 |
03/11/21 |
ASX - By Stock
|
46
|
27K
|
4
|
|
Charts
|
RHY |
Re:
RHY charts
|
|
SuperJames
|
80 |
44K |
4 |
01/11/21 |
01/11/21 |
Charts
|
80
|
44K
|
4
|
|
ASX - By Stock
|
RHY |
Re:
Ann: No Extension to Rights Issue Offer Closing Date
|
|
SuperJames
|
5 |
2.7K |
6 |
06/09/21 |
06/09/21 |
ASX - By Stock
|
5
|
2.7K
|
6
|
|
ASX - By Stock
|
360 |
Re:
Ann: Half Year Results - Investor Presentation
|
|
SuperJames
|
14 |
4.6K |
4 |
26/08/21 |
26/08/21 |
ASX - By Stock
|
14
|
4.6K
|
4
|
|
ASX - By Stock
|
DSK |
Re:
Livewire article $6 fair value
|
|
SuperJames
|
64 |
24K |
0 |
06/08/21 |
06/08/21 |
ASX - By Stock
|
64
|
24K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Rights issue to raise approximately $4.3 million
|
|
SuperJames
|
20 |
9.9K |
8 |
02/08/21 |
02/08/21 |
ASX - By Stock
|
20
|
9.9K
|
8
|
|
ASX - By Stock
|
NEA |
Re:
Ann: FY21 preliminary results, exceeds recently upgraded guidance
|
|
SuperJames
|
112 |
48K |
3 |
13/07/21 |
13/07/21 |
ASX - By Stock
|
112
|
48K
|
3
|
|
ASX - By Stock
|
RHY |
Re:
Ann: FY22 Strategic Update
|
|
SuperJames
|
9 |
5.4K |
2 |
19/05/21 |
19/05/21 |
ASX - By Stock
|
9
|
5.4K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Study 6 Successfully Concluded - Exceptional Results
|
|
SuperJames
|
15 |
8.9K |
2 |
16/03/21 |
16/03/21 |
ASX - By Stock
|
15
|
8.9K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Rhythm Expands ColoSTAT Clinical Trial To Tenth Site
|
|
SuperJames
|
2 |
1.8K |
0 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
2
|
1.8K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Appendix 4C - quarterly
|
|
SuperJames
|
12 |
5.9K |
1 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
12
|
5.9K
|
1
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Adventist Health Contracts Mach7 to Provide Mach7 PACS
|
|
SuperJames
|
12 |
4.9K |
1 |
25/01/21 |
25/01/21 |
ASX - By Stock
|
12
|
4.9K
|
1
|
|